Velocity Financial, Inc. Announces Dual Listing on NYSE Texas
Get Alerts VEL Hot Sheet
Join SI Premium – FREE
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)-- Velocity Financial, Inc. (NYSE: VEL) (“Velocity” or “Company”), a leader in investor real estate loans, announced today the dual listing of its common stock on NYSE Texas, Inc. (“NYSE Texas”), the newly launched fully electronic equities exchange headquartered in Dallas, Texas.
Velocity will maintain its primary listing on the New York Stock Exchange (“NYSE”) and continue to trade under the same ticker symbol, “VEL,” on the NYSE and NYSE Texas.
“We are pleased to join the NYSE Texas as a Founding Member, strengthening our roots in the state and we are excited to further support Texas business development with this dual listing,” said Chris Farrar, Velocity’s Chief Executive Officer.
“As a leader in providing innovative financing solutions for real estate investment, Velocity is a great addition to the NYSE Texas community,” said Chris Taylor, Chief Development Officer, NYSE Group.
About Velocity Financial, Inc.
Based in Westlake Village, California, Velocity is a vertically integrated real estate finance company that primarily originates and manages business purpose loans secured by 1-4 unit residential rental and small commercial properties. Velocity originates loans nationwide across an extensive network of independent mortgage brokers built and refined over 21 years. For additional information, please visit the Company’s investor relations website at www.velfinance.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250813584382/en/
Investors and Media:
Chris Oltmann
(818) 532-3708
Source: Velocity Financial, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rio Tinto celebrates 60 years in Western Australia
- The Baja Is Back: A Race Against Blindness Offers One Final Chance to Win $350,000 Adventure Truck Prize
- CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share